1. Home
  2. NEPH vs CPIX Comparison

NEPH vs CPIX Comparison

Compare NEPH & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • CPIX
  • Stock Information
  • Founded
  • NEPH 1997
  • CPIX 1999
  • Country
  • NEPH United States
  • CPIX United States
  • Employees
  • NEPH N/A
  • CPIX N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • CPIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEPH Health Care
  • CPIX Health Care
  • Exchange
  • NEPH Nasdaq
  • CPIX Nasdaq
  • Market Cap
  • NEPH 37.4M
  • CPIX 43.8M
  • IPO Year
  • NEPH 2004
  • CPIX 2009
  • Fundamental
  • Price
  • NEPH $4.13
  • CPIX $3.08
  • Analyst Decision
  • NEPH Strong Buy
  • CPIX
  • Analyst Count
  • NEPH 2
  • CPIX 0
  • Target Price
  • NEPH $5.50
  • CPIX N/A
  • AVG Volume (30 Days)
  • NEPH 48.3K
  • CPIX 73.6K
  • Earning Date
  • NEPH 08-07-2025
  • CPIX 08-05-2025
  • Dividend Yield
  • NEPH N/A
  • CPIX N/A
  • EPS Growth
  • NEPH N/A
  • CPIX N/A
  • EPS
  • NEPH 0.12
  • CPIX N/A
  • Revenue
  • NEPH $16,684,000.00
  • CPIX $42,071,813.00
  • Revenue This Year
  • NEPH $17.06
  • CPIX N/A
  • Revenue Next Year
  • NEPH $12.20
  • CPIX N/A
  • P/E Ratio
  • NEPH $34.23
  • CPIX N/A
  • Revenue Growth
  • NEPH 21.16
  • CPIX 11.34
  • 52 Week Low
  • NEPH $1.36
  • CPIX $1.04
  • 52 Week High
  • NEPH $5.00
  • CPIX $7.25
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 56.97
  • CPIX 43.81
  • Support Level
  • NEPH $3.75
  • CPIX $2.75
  • Resistance Level
  • NEPH $4.59
  • CPIX $3.49
  • Average True Range (ATR)
  • NEPH 0.45
  • CPIX 0.34
  • MACD
  • NEPH 0.08
  • CPIX -0.01
  • Stochastic Oscillator
  • NEPH 60.19
  • CPIX 28.30

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

Share on Social Networks: